Dr Philip Hamann
Dr Hamann (BMBS, BMedSci, MRCP, PhD) is a Consultant Rheumatologist at North Bristol NHS Trust and a Clinical Lecturer in Rheumatology at the University of Bristol. He sees his private patients at Sulis Hospital Bath. Dr Hamann is passionate about patient-centred holistic care and devotes time and care to listen, understand and treat all rheumatological conditions.
Dr Hamann is a Member of the Royal College of Physicians. He graduated from the University of Nottingham in 2006 before undertaking clinical training at Guy’s and St Thomas’ Hospital, the Royal National Hospital for Rheumatic Diseases in Bath, and North Bristol NHS Trust where he now practices as a Consultant Rheumatologist.
In addition to his clinical expertise, Dr Hamann has a strong academic career. He regularly attends and speaks at international conferences, is up to date on the latest research evidence, and brings complex critical appraisal skills to his clinical practice. Dr Hamann’s PhD used data from over 15,000 clinical records to understand how people with rheumatoid arthritis respond to high-cost drugs, and identified predictors of response to these drugs.
Fast track your treatment with Dr Philip Hamann
We are here to answer any questions you might have and can provide a guide price. Simply fill in your details below.
Additional information about Dr Philip Hamann
Recently, Dr Hamann’s research has focused on methods to improve remote consultation and monitoring for patients, motivated by the need to keep immunosuppressed patients safe during the COVID-19 pandemic. He has pioneered remote clinics to help deliver high-quality care in a convenient and efficient manner for patients and has been shortlisted for the British Society for Rheumatology Best Practice Award for this work. He is one of the founding members of the British Society for Rheumatology Special Interest Group for Telemedicine and Remote Monitoring, a former Fellow of the Turing Institute (the UK Centre for Artificial Intelligence Research), and an alumnus of the NHS Clinical Entrepreneur Fellowship programme.
He takes the time his patients need to discuss their medical history in detail and works to form a clear, holistic and evidence-based diagnosis and management plan.
Dr Hamann conceptualised and developed the award-winning Living With Arthritis smartphone app with industry partners which allows patients to securely record and report how active their arthritis disease activity is to their doctors. This app allows doctors to know exactly how their patients are doing remotely and improves the quality and efficiency of both remote and face-to-face consultations and is used across the UK in the NHS by thousands of patients.
In addition to developing innovative solutions to improve clinical care for his patients, Dr Hamann has a strong research background and continues to be actively involved in research.
His research interests centre on using real-world health data to help develop methods to monitor and manage individuals with arthritis using remotely captured data from smartphones and wearables. His PhD used real-world data from over 15,000 patient clinical records to understand how people with rheumatoid arthritis respond to high-cost drugs and identified predictors of response to these drugs. His research has been presented at both national and international conferences. Dr Hamann is one of the founding members of the British Society for Rheumatology Special Interest Group for Telemedicine and Remote Monitoring.
Consultant Rheumatologist and Honorary Clinical Lecturer North Bristol NHS Trust and University of Bristol
General Rheumatology Experience
I currently see a wide range of patients in my rheumatology clinics. My clinical case mix includes inflammatory arthritis (including rheumatoid arthritis, inflammatory spinal conditions, psoriatic arthritis, giant cell arteritis, polymyalgia rheumatica and gout) and non-inflammatory soft-tissue musculoskeletal conditions such as osteoarthritis and fibromyalgia.
I am experienced in providing care for patients within sub-specialty clinics. These include:
● Connective tissue diseases
● Psoriatic arthritis
● Ankylosing spondylitis
● Osteoporosis (including DEXA reporting)
● Pain clinics
I am proficient in a wide range of joint injections and have run weekly injection clinics. I also routinely perform joint injections as required in both inpatient and outpatient settings. I am competent in the following injection techniques:
● Greater Trochanteric Bursitis
● Hands (MCPJ, PIPJ, CMCJ)
● Trigger finger
● Carpal Tunnel
● De Quervains Tenosynovitis
● Medial and Lateral Epicondylitis
● Bicipital Tendinitis
● Shoulders (including subacromial, and glenohumeral approaches)
● Feet (MTPJ and TMTJ)
● Plantar Fasciitis
My research interests centre on the use of novel technologies (such as smartphone apps and wearables) and artificial intelligence to support remote monitoring in arthritis. I aim to use these novel tools to improve the quality and efficiency of follow-up for people with these conditions.
I have published eleven papers (nine as first author) and two book chapters. I have also developed an online disease activity scoring tool and have established international collaborations with researchers to validate work undertaken during my Ph.D.
I am passionate about innovation to solve problems within healthcare. Whilst studying for my PhD in 2015, I conceptualised a remote patient monitoring app and a cloud-based platform to solve the problem of unnecessary face-to-face consultations.
The idea won the University of Bath Apps Crunch competition and I worked with a digital health tech start-up to develop and deploy the solution across the UK. The App facilitated a rapid shift to non-face-to-face consultations at the start of the pandemic, enabling remote patient monitoring, and was shortlisted for the British Society for Rheumatology Best Practice Award 2022. I was also successful in my application to be one of the first cohorts of NHS Clinical Entrepreneurs.
Royal College of Physicians (London)
British Society for Rheumatology
“Thank you. I feel like a new woman since my shoulder injection, it’s probably the first time in years I don’t have any pain.”
Shortlisted for the British Society for Rheumatology Best Practice Award in 2022.